Compared with diabetic patients not on insulin, those receiving insulin treatment had reduced renal function, higher BMI and HbA1c levels, as well as a higher CHA2DS2–VASC score, due to a higher prevalence of heart failure, peripheral artery disease, coronary heart disease and previous ischemic stroke. This evidence concerns the gene INS and coronary artery disorder.